Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
2020 | RavenQuest BioMed Inc. announced that it has received CAD 0.480718 million in funding | CI |
2020 | RavenQuest BioMed Inc. announced that it expects to receive CAD 1 million in funding | CI |
Business Summary
Sales per Business
CAD in Million | 2017 | Weight | 2018 | Weight | Delta |
---|---|---|---|---|---|
Consulting
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +1,018.58% |
Sales per region
CAD in Million | 2017 | Weight | 2018 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +1,018.58% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jay Dhaliwal
CEO | Chief Executive Officer | 35 | 26/11/19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jay Dhaliwal
CEO | Chief Executive Officer | 35 | 26/11/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 123,913,559 | 110,882,259 ( 89.48 %) | 0 | 89.48 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
6,764,945 | 8.66% | 805,028 $ |
Company contact information
RavenQuest BioMed, Inc.
580 Hornby Street Suite 780
V6C 3B6, Vancouver
+877-282-1586
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-.--% | 182 | |
+10.90% | 7.75B | |
-35.02% | 3.23B | |
+9.25% | 2.74B | |
-2.16% | 1.57B | |
-9.84% | 1.08B | |
+23.26% | 851M | |
-10.41% | 707M | |
-4.92% | 598M | |
-13.76% | 573M |
- Stock Market
- Equities
- RVVQF Stock
- Company RavenQuest BioMed Inc.